Stay updated on Pembrolizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a minor internal update without changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-29T21:51:46.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, signaling a minor update to the page's content or formatting. No core study information, eligibility criteria, or results appear to be affected.
    Difference
    0.1%
    Check dated 2026-08-08T16:47:14.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a revision label of v3.6.4, replacing the previous v3.6.3. This reflects a minor page version update.
    Difference
    0.1%
    Check dated 2026-07-25T09:23:27.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.6.3 replaces the previous Revision: v3.6.2 in the page metadata. This reflects a minor update to the page rendering without changing the study data.
    Difference
    0.1%
    Check dated 2026-07-03T22:43:30.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page now displays a new Revision: v3.6.2 label, replacing the previous Revision: v3.6.0, indicating a newer page version.
    Difference
    0.1%
    Check dated 2026-06-26T20:54:28.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Recruitment status now indicates that no participants are being sought. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the treatment header formatting was updated along with a revision tag increment from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T14:28:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.